Melissa MJ Farnham
Clinical Oncology Society of Australia Annual Scientific Meeting 2026
Days
Wednesday, 11th November
Thursday, 12th November
Friday, 13th November
Search
Speakers
Melissa MJ Farnham
Abstracts this author is presenting:
Sustained remission and long-term survival outcomes with dostarlimab plus chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial (Encore)
—
Wednesday Poster Session